Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Karlskrona
Clinical trial register · Sweden

Clinical Trials in Karlskrona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Karlskrona

28 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease
NCT07836764COPD (Chronic Obstructive Pulmonary Disease), Asthma (Diagnosis), Interstitial Lung Disease (ILD)
Jacob Sandberg
Observational
120
Karlskrona
2026-11-01
Recruiting
Region Skane
Phase 2
20
Karlskrona, Lund
2026-05-07
Recruiting
Region Skane
Phase 2
20
Karlskrona, Lund
2026-04-13
Recruiting
Blekinge Institute of Technology
Not applicable
90
Karlskrona
2026-04-10
Not yet open
Simplified Exercise-based Risk Assessment in Lung Cancer
NCT07506889Lung Cancer (Diagnosis), Lobectomy, Surgery Complications, Neoadjuvant Chemoimmunotherapy
Linkoeping University
Observational
500
Jönköping, Kalmar, Karlskrona, Linköping, Lund
2026-04-01
Not yet open
Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity
NCT07263399Oxygen Toxicity, Oxidative Stress, Hyperoxia, Hyperbaric Oxygen
Blekinge Institute of Technology
Not applicable
32
Karlskrona
2026-01
Recruiting
Uppsala University
Phase 4
560
Borås, Eskilstuna, Gothenburg, Karlskrona, Lund, Örebro, Stockholm, Sundsvall
2025-12
Not yet open
Blekinge Institute of Technology
Observational
2,000
Karlskrona
2025-08-30
Not yet open
Blekinge Institute of Technology
Not applicable
50
Karlskrona
2025-08
Recruiting
AstraZeneca
Phase 3
990
Gothenburg, Karlskrona, Lund, Örebro, Stockholm
2025-03-25
Not yet open
Sleep-Disordered Breathing in the Acute Phase After Stroke and Neuropsychiatric Outcomes
NCT06811948Stroke, Fatigue Symptom, Obstructive Sleep Apnea, Sleep Disordered Breathing (SDB)
Blekinge County Council Hospital
Observational
340
Karlskrona
2025-02-20
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke
Region Skane
Phase 4
3,500
Eksjö, Gothenburg, Hässleholm, Helsingborg, Huddinge, Jönköping, Kalmar, Karlskrona
2025-01-07
Active, closed
Blekinge Institute of Technology
Observational
48
Karlskrona
2024-10-28
By invitation
Blekinge County Council Hospital
Observational
200
Karlskrona, Kungsbacka, Ljungby, Lund
2024-09-01
Recruiting
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
NCT06247397Chronic Obstructive Pulmonary Disease Severe, Interstitial Lung Disease, Chronic Respiratory Failure With Hypoxia
Skane University Hospital
Not applicable
310
Karlskrona, Örebro
2024-06-10
Active, closed
Blekinge Institute of Technology
Observational
68
Karlskrona
2023-11-28
Active, closed
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
NCT05284747Cardiovascular Disease, Myocardial Infarction, Stroke, Coronary Revascularization
Amgen
Phase 4
6,019
Alingsås, Gävle, Jönköping, Karlskrona, Linköping, Luleå, Lund, Molndahl
2022-10-26
Recruiting
Blekinge Institute of Technology
Observational
30
Karlskrona
2022-08-15
Active, closed
GlaxoSmithKline
Phase 3
3,038
Borås, Gothenburg, Karlskrona, Linköping, Malmö, Örebro, Stockholm, Upplands Vasby
2022-08-10
Recruiting
Blekinge County Council Hospital
Not applicable
360
Karlskrona
2022-05-01
Active, closed
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
NCT04562805Coronary Artery Disease, Ischemic Heart Disease
Elixir Medical Corporation
Not applicable
2,400
Eskilstuna, Halmstad, Helsingborg, Karlskrona, Karlstad, Lund, Malmö, Örebro
2020-09-30
Recruiting
Malmö University
Observational
650
Karlskrona, Malmö
2020-08-30
Active, closed
Vastra Gotaland Region
Phase 4
2,201
Gothenburg, Karlskrona, Linköping, Lund, Örebro, Stockholm, Umeå, Uppsala
2018-06-29
Active, closed
Anna Martling
Phase 3
626
Falun, Gothenburg, Jönköping, Karlskrona, Karlstad, Linköping, Luleå, Malmö
2016-04-07
Active, closed
Lund University
Observational
985
Karlskrona, Halmstad, Helsingborg, Vaxjo
2016-02-15
Active, closed
Karolinska Institutet
Not applicable
2,766
Gävle, Gothenburg, Halmstad, Helsingborg, Jönköping, Kalmar, Karlskrona, Karlstad
2015-01-27
Recruiting
Olof Akre
Not applicable
1,200
Falun, Gothenburg, Helsingborg, Jönköping, Karlskrona, Linköping, Malmö, Norrköping
2014-10
Recruiting
Lund University
Observational
20,000
Borås, Halmstad, Helsingborg, Jönköping, Karlskrona, Kristianstad, Lund, Malmö
2010-08
Rows per page Showing 1–28 of 28
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/karlskrona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 28 of those studies with a site in Karlskrona.

How many clinical trials are recruiting in Karlskrona?

12 of the 28 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 6 have not yet opened recruitment, 9 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Karlskrona), 28 studies
PhaseStudiesRecruitingShare
Observational11339.3%
Not applicable8428.6%
Phase 44214.3%
Phase 33110.7%
Phase 2227.1%

Most active sponsors

Lead sponsors with the most studies (Karlskrona)
Lead sponsorStudiesRecruiting
Blekinge Institute of Technology72
Blekinge County Council Hospital31
Region Skane33
Lund University21
Amgen10
Anna Martling10
AstraZeneca11
Elixir Medical Corporation10
GlaxoSmithKline10
Jacob Sandberg10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.